Home
Conditions
Multiple Myeloma (MM)

Clinical trial condition

Multiple Myeloma (MM)

Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma (MM) trial results

Not Yet Recruiting

A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma

NCT07735546

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification

NCT07687004

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Not Yet Recruiting

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

NCT07684274

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07649681

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +42 more
Locations: Universitätsklinikum Augsburg Augsburg, Bavaria, Germany

Universitätsklinikum Erlangen Erlangen, Bavaria, Germany

LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center München, Bavaria, Germany

Klinikum der Technischen Universität München (TUM Klinikum) München, Bavaria, Germany

View Trial Details

Not Yet Recruiting

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

NCT07660939

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

PET-Enabled Dual-Energy CT in Multiple Myeloma

NCT07646873

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UC Davis EXPLORER Molecular Imaging Center Sacramento, California, United States

View Trial Details

Not Yet Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

NCT07637578

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma

NCT07628595

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.

NCT07539233

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

BR101 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07537049

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Multiple Myeloma (MM)

Multiple Myeloma (MM) trial results

Related conditions